Insights On Enterprise Solutions

  1. Advancing Cell Culture Strategies To Accelerate Biologics Development 5/5/2026

    Integrated stable expression strategies accelerate biologics material generation, improving scalability, consistency, and early developability insights while reducing bottlenecks, variability, and risks in transitioning from discovery to manufacturing.

  2. Solving The DNA Knock-In Problem 5/1/2026

    An in‑depth exploration of why large, precise DNA knock‑ins limit cell therapy progress—and how site‑specific integration enables durable, scalable genetic engineering solutions.

  3. Expanding The Capabilities Of Targeted Integration 5/1/2026

    See the demonstration of precise, site‑specific integration of a 50 kb multi‑gene construct into human iPSCs, overcoming size limits of traditional genome‑engineering approaches.

  4. Bispecific T- Cell Engager (BiTE) Screening, Automated Pipeline 5/1/2026

    View automated, high‑throughput BiTE screening in mammalian cells, enabling rapid discovery of efficacious variants through precise genomic integration and scalable workflows.

  5. Adding Expertise In Connection Technology 4/30/2026

    Discover how decades of innovation in sterile connectivity and integrated flow control expertise are empowering manufacturers to solve their most critical fluid transfer challenges.

  6. Advancing Formulation Strategies for Complex Drug Products 4/30/2026

    An event-focused overview examining how formulation development and stability strategies support robust, scalable drug products discussed at the DDF Summit Berlin.

  7. Engineering Precision In Genetic Medicines 4/30/2026

    Precision genome editing strategies that balance specificity and potency through advanced engineering workflows, AI‑driven optimization, and tailored editor design for clinical genetic medicines.

  8. Fast Path To Market: Going From GMP1 To PPQ In Just 12 Months 4/30/2026

    Learn how focused optimization and coordinated execution helped overcome technical uncertainty and enable faster progression to market readiness.

  9. Redefining Cell Line Development For Next-Generation Biologics 4/30/2026

    A transposon‑enabled cell line development strategy streamlines upstream optimization, shortening timelines while improving consistency, yield, and quality across recombinant protein modalities.

  10. Standardized Extraction Protocol Per USP <665>: Bridging Regulatory Expectations And Industry Best Practices 4/29/2026

    View how to implement USP <665> extractables testing, align with global E&L standards, and apply risk-based strategies to ensure regulatory compliance and patient safety.